Unavailable Treatments

Unfortunately, treatments and over-the-counter products occasionally become unavailable for a variety of reasons.

See below for updates on the unavailable treatments that we are aware of, but please do get in touch with us if you become aware of an issue that is not listed below. We are not always contacted by treatment manufacturers when there is an availability concern, and so we do rely on the information of our supporters.

Clarelux Foam

In October 2018, we were contacted by Pierre Fabre Dermo-Cosmetique, the manufacturer of topical corticosteroid treatment, Clarelux foam, regarding the ongoing unavailability of the product. They confirmed that, due to supply issues with the product, they do not currently know when it will be back on the market again. The latest estimate is 2020.

There are no safety issues with the product so available stock can still be used.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0208 731 3322, or by email at medicalinformation@pierre-fabre.co.uk.

Ceanel Shampoo

In summer 2018 we received a number of reports of difficulty obtaining Ceanel Shampoo, which is commonly used to manage scalp psoriasis. In September 2018 we contacted Alliance Pharmaceuticals, the manufacturer of Ceanel Shampoo, who confirmed that the product is currently out of production and they do not yet have a date for when it may be available again.

A representative from the manufacturer stated 'Unfortunately, Ceanel shampoo is currently out of production as we are having difficulty in sourcing some of the raw materials. We do not have a date for when it may be available.

In the meantime, we would recommend that patients discuss suitable alternatives with a healthcare professional (e.g. GP or Pharmacist).

There were no safety concerns for products on the market, however, all stock will now have passed its expiry date.'

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01249 466 966, or by email at medinfo@alliancepharma.co.uk. 

Zorac Gel

We were contacted in August 2017 by a Psoriasis Association supporter who was having difficulty obtaining Zorac Gel (tazarotene) from their pharmacy.

We contacted the manufacturer - Allergan Ltd - who confirmed that Zorac Gel was out of stock. It was hoped that stock availability would resume by mid August 2017, and would be delivered to wholesalers UK-wide from then on.

If you have any further questions about the availability of Zorac Gel, please get in touch with Allergan Ltd on their Medical Information line: 01628 494026.


In June 2017, the manufacturers of Enstilar, LEO Pharma, issued the Psoriasis Association with the following statement:

Enstilar® cutaneous foam will be temporarily unavailable in the UK from the beginning of June 2017 due to an unforeseen technical issue in the manufacturing process. At time of writing we anticipate supply to resume in July with the potential for intermittent supply over the summer months. LEO Pharma is currently working to restore full supply as soon as possible. We will keep all parties updated with developments on our web site: www.leo-pharma.co.uk

We sincerely apologise for any inconvenience that this may cause you and your members. Our aim is to ensure treatment continuity and availability of LEO products for patients.

There are no safety or quality issues with current stock; available stock can be used.


As of the start of July 2017, Enstilar foam supply has now resumed. However, fluctuations in supply are expected to continue whilst stock flow normalises.


After many people expressed concern over the disappearance of the Polytar® range for a number of months, the manufacturers confirmed its discontinuation in 2014.

A statement received by the Psoriasis Association from the manufacturer of Polytar (GSK) reads:-

"We understand how important Polytar® is for our consumers and have been working diligently to identify how we could bring the brand back to market since 2012. Providing our consumers with the highest quality products is our main priority. We have had to take the difficult decision to discontinue the current range as we have been unable to source a supply of the active ingredient which would meet even basic Good Manufacturing Practice (GMP) standards. We appreciate this is upsetting for those consumers who have relied on these products for a number of years. However, we are urgently exploring alternative product options and hope to launch an alternative product in the future.”

The discontinuation applies to Polytar® Liquid, Polytar® Plus and Polytar® Emollient.

If you still have supplies of Polytar®, they can still be used (providing they are still in date).  Should you wish to discuss any further with the manufacturer please contact GSK Customer Relations on 0800 783 8881 or customer.relations@gsk.com


Polytar shampoo was re-launched in July 2016. Unfortunately, the rest of the Polytar range remains discontinued.

Haelan Tape

In October 2016, we received information that the branded Haelan Tape had been discontinued by the manufacturer, Typharm. A generic version - Fludroxycortide Tape - is available, however this was in limited supply due to an ongoing manufacturing issue. Typharm hoped to resolve this issue in early 2017.

The Psoriasis Association is the UK's leading national charity and membership organisation for people affected by psoriasis – patients, families, carers and health professionals Read More >

Get in touch

The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF

Email: mail@psoriasis-association.org.uk

Tel :
01604 251 620
Fax :
01604 251 621
Registered with Fundraising Regulator -

© The Psoriasis Association Registered Charity: 257414 Scotland: SC039886 Privacy PolicyCookies

Site by Spoken Image | glitterfish

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you.

If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them.